The Neurovascular Devices/Interventional Neurology Market size is estimated to reach $3.4 Billion by 2025, growing at a CAGR of 9.1% during the forecast period 2020-2025. Neurovascular/interventional neurology devices are used to treat several neurovascular diseases including aneurysms, arteriovenous malformations, atherosclerosis, and moyamoya diseases that affect the Blood Vascular system as well as the Central Nervous system associated with it. Factors such as favourable medical reimbursements large target patient population base, ongoing product development & commercialization, and expansion of healthcare infrastructure is driving the growth of the Neurovascular Devices/Interventional Neurology Market during the forecast period 2020-2025.
Neurovascular Devices/Interventional Neurology Market Report Coverage
Key Takeaways
- Geographically, North America held largest market share in the Neurovascular Devices/Interventional Neurology Market in 2019. This is owing to the increasing number of clinical trial and large patient population for target diseases.
- The factors such as the increasing number of research activities in the field of neurovascular therapies and rising demand for minimally invasive neurosurgical procedures are set to offer renewed growth opportunities for the market players during the forecast period 2020-2025.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Neurovascular Devices/Interventional Neurology Market report.
Neurovascular Devices/Interventional Neurology Market Segment Analysis - By Product Type
Neurovascular Devices/Interventional Neurology Market Segment Analysis - By Disease
Neurovascular Devices/Interventional Neurology Market Segment Analysis - By Geography
Neurovascular Devices/Interventional Neurology Market Drivers
- Rising popularity of neurovascular diseases:
Neurovascular Devices/Interventional Neurology Market Challenges
Neurovascular Devices/Interventional Neurology Market Industry outlook:
Neurovascular Devices/Interventional Neurology Market Developments:
- In January 2017, Abbott Laboratories has acquired St. Jude Medical The transaction provides Abbott with expanded opportunities for future growth and is an important part of the company's ongoing effort to develop a strong, diverse portfolio of Neurovascular devices, diagnostics, nutritionals and branded generic pharmaceuticals.
Post a Comment